LV11818B - Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide - Google Patents

Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide Download PDF

Info

Publication number
LV11818B
LV11818B LVP-97-29A LV970029A LV11818B LV 11818 B LV11818 B LV 11818B LV 970029 A LV970029 A LV 970029A LV 11818 B LV11818 B LV 11818B
Authority
LV
Latvia
Prior art keywords
parts
metoclopramide
acetylsalicylic acid
composition according
pharmaceutically acceptable
Prior art date
Application number
LVP-97-29A
Other languages
English (en)
Latvian (lv)
Other versions
LV11818A (lv
Inventor
Bru Nicole
Cordoliani Jean-Francois
Poly Pierre-Andre
Drouin Jehan-Yves
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Publication of LV11818A publication Critical patent/LV11818A/xx
Publication of LV11818B publication Critical patent/LV11818B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-97-29A 1993-11-26 1997-02-21 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide LV11818B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9314170A FR2712809B1 (fr) 1993-11-26 1993-11-26 Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
PCT/FR1994/001374 WO1995014462A1 (fr) 1993-11-26 1994-11-25 Nouvelle composition pharmaceutique destinee a la preparation d'une poudre stable contenant, a titre d'ingredient actif, une association d'acide acetylsalicylique et de metoclopramide

Publications (2)

Publication Number Publication Date
LV11818A LV11818A (lv) 1997-08-20
LV11818B true LV11818B (en) 1997-12-20

Family

ID=9453264

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-29A LV11818B (en) 1993-11-26 1997-02-21 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide

Country Status (25)

Country Link
US (1) US5437874A (ru)
EP (1) EP0693926B1 (ru)
JP (1) JP3195356B2 (ru)
KR (1) KR100351193B1 (ru)
CN (1) CN1083260C (ru)
AT (1) ATE147623T1 (ru)
AU (1) AU693137B2 (ru)
CA (1) CA2175470C (ru)
CZ (1) CZ287757B6 (ru)
DE (1) DE69401502T2 (ru)
DK (1) DK0693926T3 (ru)
ES (1) ES2099649T3 (ru)
FI (1) FI116883B (ru)
FR (1) FR2712809B1 (ru)
GR (1) GR3023074T3 (ru)
HU (1) HU226895B1 (ru)
LV (1) LV11818B (ru)
NO (1) NO309024B1 (ru)
NZ (1) NZ276740A (ru)
RU (1) RU2146518C1 (ru)
SI (1) SI0693926T1 (ru)
SK (1) SK278986B6 (ru)
TW (1) TW372193B (ru)
UA (1) UA40636C2 (ru)
WO (1) WO1995014462A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
FR2753097A1 (fr) * 1996-09-11 1998-03-13 Barrau Francois Gel aqueux ou hydroalcoolique extemporane a viscosite controlee
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
DE19807535A1 (de) * 1998-02-21 1999-08-26 Asta Medica Ag Pharmazeutische Kombinationen mit Tramadol
US6376550B1 (en) * 1999-02-09 2002-04-23 Asta Medica Ag Pharmaceutical compositions containing tramadol for migraine
US6596708B1 (en) 2001-09-07 2003-07-22 Advanced Medical Instruments Composition for the treatment and prevention of endothelial dysfunction
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
EP1736156A4 (en) * 2004-04-15 2010-06-16 Eisai R&D Man Co Ltd COMPOSITION CONTAINING 4-AMINO-5-CHLORO-N-¬ (1R, 3R, 5S) -8-METHYL-8-AZABICYCLO-3.2.1 OCT-3-YL-2-β-methyl-2-ynyloxy BENZAMIDE STABILIZED
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
CN117982446A (zh) * 2016-06-28 2024-05-07 阿萨德股份有限公司 双组分组合物
CN113354553B (zh) * 2021-06-03 2023-09-15 北京宝诺康医药科技有限公司 一种甲氧氯普胺单盐酸盐一水合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380540A (en) * 1978-11-14 1983-04-19 Beecham Group Limited Tablets
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
AU528310B2 (en) * 1978-11-16 1983-04-21 Beecham Group Plc Composition of paracetamol and metoclopramide
JPS5940102B2 (ja) * 1978-11-17 1984-09-28 日本クラウンコルク株式会社 剥離可能な接着構造物
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
IT1246350B (it) * 1990-07-11 1994-11-17 Eurand Int Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili

Also Published As

Publication number Publication date
JPH09505576A (ja) 1997-06-03
TW372193B (en) 1999-10-21
AU1112395A (en) 1995-06-13
LV11818A (lv) 1997-08-20
NZ276740A (en) 1997-03-24
SK63896A3 (en) 1997-04-09
RU2146518C1 (ru) 2000-03-20
DK0693926T3 (da) 1997-07-14
CA2175470A1 (en) 1995-06-01
CZ149996A3 (en) 1996-08-14
CZ287757B6 (en) 2001-01-17
CA2175470C (en) 2003-11-04
NO962129L (no) 1996-05-24
US5437874A (en) 1995-08-01
DE69401502T2 (de) 1997-06-12
CN1136274A (zh) 1996-11-20
FI116883B (fi) 2006-03-31
ATE147623T1 (de) 1997-02-15
CN1083260C (zh) 2002-04-24
FR2712809A1 (fr) 1995-06-02
HU226895B1 (en) 2010-01-28
SI0693926T1 (en) 1997-10-31
FR2712809B1 (fr) 1996-04-12
GR3023074T3 (en) 1997-07-30
HU9601416D0 (en) 1996-07-29
UA40636C2 (ru) 2001-08-15
FI962056A0 (fi) 1996-05-15
DE69401502D1 (de) 1997-02-27
KR100351193B1 (ko) 2002-12-31
FI962056A (fi) 1996-05-15
AU693137B2 (en) 1998-06-25
NO962129D0 (no) 1996-05-24
JP3195356B2 (ja) 2001-08-06
ES2099649T3 (es) 1997-05-16
WO1995014462A1 (fr) 1995-06-01
HUT75230A (en) 1997-04-28
NO309024B1 (no) 2000-12-04
EP0693926A1 (fr) 1996-01-31
EP0693926B1 (fr) 1997-01-15
SK278986B6 (sk) 1998-05-06

Similar Documents

Publication Publication Date Title
BE1015217A5 (ru)
AU725760B2 (en) Process for making flurbiprofen lozenges
LV11818B (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
EP1773450B1 (fr) Combinaisons therapeutiques
EP0673245A1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation.
KR20120011031A (ko) 아세틸살리실산과 테아닌의 수용성 공결정을 이용한 정맥내 투여 제제
JPH0948728A (ja) 解熱鎮痛剤
US11369581B2 (en) Two component composition
WO2009083686A9 (fr) Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
ES2700251T3 (es) Composición farmacéutica de ibuprofeno, tramadol y un aminoácido básico, procedimiento para su preparación y utilización de la misma
EP2574333B1 (en) N-acetylcysteine effervescent tablet and its therapeutical applications
JPH07112973B2 (ja) イブプロフェン又はその塩を活物質とする可溶性の消炎性組成物及びその製造方法
BE1017903A3 (fr) Compositions pharmaceutiques a activite antibiotique.
US11850253B2 (en) Two component compositions
CN101203210A (zh) 水溶性止痛药制剂和生产方法
EP3727395B1 (en) Two-component systems comprising acetylsalicylic acid and a phosphate salt
US20070092561A1 (en) Water-Soluble Aspirin Composition
EP0919239A1 (fr) Composition pour le traitement des gastro-entérites aigues, comprenant une solution de réhydratation avec un composé à action synérgique
US5164379A (en) Sucralfate/cyclodextrin complexes
EP0695546A1 (fr) Poudres à base de métoclopramide et de paracétamol ou de dérivés d'acide acétylsalicyclique
LU84750A1 (fr) Nouvelles argiles modifiees,leur procede de preparation et compositions therapeutiques a base de ces argiles
FR2814679A1 (fr) Compositions pharmaceutiques dispersibles a base de cephalosporines, leur procede de preparation et leur utilisation
FR2902337A1 (fr) Comprimes a liberation immediate et leur production
FR2669822A1 (fr) Composition pharmaceutique a base d'acide alginique se presentant sous forme d'une mousse.
JP2007091674A (ja) 注射用の医薬組成物